Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,216 | 1,410 | 6,029 | 5,475 | 7,779 |
| Marketable Securities | 21,495 | 14,007 | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | 134 | N/A |
| TOTAL | $25,320 | $16,727 | $6,228 | $5,775 | $7,887 |
| Non-Current Assets | |||||
| PPE Net | 41 | 54 | 12 | 46 | 68 |
| Other Non-Current Assets | 9 | 9 | 9 | 11 | 11 |
| TOTAL | $50 | $63 | $21 | $56 | $79 |
| Total Assets | $25,370 | $16,789 | $6,249 | $5,832 | $7,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 851 | 1,366 | 264 | 106 | 250 |
| Accrued Expenses | 1,289 | 281 | 570 | 193 | 45 |
| TOTAL | $2,140 | $1,647 | $834 | $299 | $294 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 1,839 | 521 | 1,655 | 15 | 54 |
| TOTAL | $1,839 | $521 | $1,655 | $15 | $54 |
| Total Liabilities | $3,978 | $2,167 | $2,489 | $314 | $349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,146 | 41,421 | 24,742 | 21,655 | 18,043 |
| Common Shares | 54 | 41 | 25 | 19 | 18 |
| Retained earnings | -54,334 | -42,179 | -38,103 | -31,712 | -27,705 |
| TOTAL | $21,391 | $14,622 | $3,761 | $5,518 | $7,618 |
| Total Liabilities And Equity | $25,370 | $16,789 | $6,249 | $5,832 | $7,966 |